weight loss drug news today glp-1 october 2025 Weight-Loss Demonstration Begins July 2026 Popular GLP-1 medications may have

For patients experiencing significant symptoms, temporarily pausing therapy, maintaining the current dose for an additional 2-4 weeks before advancing, or implementing smaller dose increments when formulation allows, may improve tolerance

However, most diagnostic tests will take place in an outpatient setting

doi: 10.1186/S13058-020-01296-5 139 AlmansourNM

Turn the vial upside down, ensuring the needle tip stays below the liquid level

GLP-1 agonists can help lower inflammation, a common lipedema issue, by improving metabolic health and reducing adipose tissue

Other important safety considerations include injection site reactions, increased heart rate (a class effect, though potentially more pronounced with liraglutide), and risk of pancreatitis (which requires immediate discontinuation if suspected)